LXRX: Lexicon Pharmaceuticals Inc
LXRX exchange rate has changed by 19.08% for today. During the day, the instrument was traded at a low of 1.33 and at a high of 1.65.
Follow Lexicon Pharmaceuticals Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
LXRX News
- FDA clears Lexicon’s pilavapadin to advance to Phase 3 trials
- Progress Software Posts Upbeat Q4 Earnings, Joins ServisFirst Bancshares, Zura Bio And Other Big Stocks Moving Higher On Wednesday - American Resources (NASDAQ:AREC), ARM Holdings (NASDAQ:ARM)
- Viatris launches heart failure drug Inpefa in UAE, first outside US
- Lexicon Pharmaceuticals, Inc. (LXRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Lexicon publishes preclinical data validating ACSL5 as obesity target
- Lexicon Pharma Has Multiple Paths To Upside, But Formidable Hurdles As Well (LXRX)
- Tilray Brands, SuperX AI Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Anglogold Ashanti (NYSE:AU), Abacus Global Management (NASDAQ:ABL)
- Xpeng, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Lexicon Pharmaceuticals (NASDAQ:LXRX), Dell Technologies (NYSE:DELL)
- Lexicon Pharmaceuticals: A Lottery Ticket With 3 Chances To Win (NASDAQ:LXRX)
- Lexicon Pharmaceuticals, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:LXRX) 2025-11-12
- Lexicon Q3 2025 slides: Revenue surges amid pipeline advancement
- Lexicon Pharmaceuticals (LXRX) Reports Q3 Loss, Beats Revenue Estimates
- Lexicon earnings beat by $0.03, revenue topped estimates
- Dianthus Therapeutics, Inc. (DNTH) Reports Q3 Loss, Lags Revenue Estimates
- Lexicon Pharmaceuticals, Inc. (LXRX) Presents at Arrowhead's 19th Annual Pain Therapeutics Summit - Slideshow (NASDAQ:LXRX) 2025-10-15
- Lexicon advances pilavapadin to Phase 3 for diabetic nerve pain
- Lexicon submits additional data for its diabetes drug to US FDA
- Lexicon Pharmaceuticals stock maintains Buy rating at H.C. Wainwright
- Lexicon Pharmaceuticals stock rises as H.C. Wainwright reiterates Buy rating
- Lexicon submits new data to FDA for potential diabetes drug approval
- H.C. Wainwright reiterates Buy rating on Lexicon Pharmaceuticals stock at $4
- Lexicon Pharmaceuticals’ Strategic Retrenchment Will Take Years To Show Results (LXRX)
- Lexicon (LXRX) Upgraded to Buy: Here's What You Should Know
- Jefferies raises Lexicon Pharmaceuticals stock price target to $0.85
Frequently Asked Questions
What is LXRX stock price today?
Lexicon Pharmaceuticals Inc stock is priced at 1.56 today. It trades within 1.33 - 1.65, yesterday's close was 1.31, and trading volume reached 6893. The live price chart of LXRX shows these updates.
Does Lexicon Pharmaceuticals Inc stock pay dividends?
Lexicon Pharmaceuticals Inc is currently valued at 1.56. Dividend policy depends on the company, while investors also watch 97.47% and USD. View the chart live to track LXRX movements.
How to buy LXRX stock?
You can buy Lexicon Pharmaceuticals Inc shares at the current price of 1.56. Orders are usually placed near 1.56 or 1.86, while 6893 and 16.42% show market activity. Follow LXRX updates on the live chart today.
How to invest into LXRX stock?
Investing in Lexicon Pharmaceuticals Inc involves considering the yearly range 0.28 - 1.66 and current price 1.56. Many compare 34.48% and 45.79% before placing orders at 1.56 or 1.86. Explore the LXRX price chart live with daily changes.
What are Lexicon Pharmaceuticals Inc stock highest prices?
The highest price of Lexicon Pharmaceuticals Inc in the past year was 1.66. Within 0.28 - 1.66, the stock fluctuated notably, and comparing with 1.31 helps spot resistance levels. Track Lexicon Pharmaceuticals Inc performance using the live chart.
What are Lexicon Pharmaceuticals Inc stock lowest prices?
The lowest price of Lexicon Pharmaceuticals Inc (LXRX) over the year was 0.28. Comparing it with the current 1.56 and 0.28 - 1.66 shows potential long-term entry points. Watch LXRX moves on the chart live for more details.
When did LXRX stock split?
Lexicon Pharmaceuticals Inc has gone through stock splits historically. These changes are visible in , 1.31, and 97.47% after corporate actions.
- Previous Close
- 1.31
- Open
- 1.34
- Bid
- 1.56
- Ask
- 1.86
- Low
- 1.33
- High
- 1.65
- Volume
- 6.893 K
- Daily Change
- 19.08%
- Month Change
- 34.48%
- 6 Months Change
- 45.79%
- Year Change
- 97.47%
- Act
- Fcst
- Prev
- Act
- Fcst
- 223 K
- Prev
- 198 K
- Act
- Fcst
- 1.928 M
- Prev
- 1.884 M
- Act
- Fcst
- 0.2%
- Prev
- 0.2%
- Act
- Fcst
- 2.7%
- Prev
- 2.8%
- Act
- Fcst
- 0.2%
- Prev
- 0.3%
- Act
- Fcst
- 2.9%
- Prev
- 2.8%
- Act
- Fcst
- 0.3%
- Prev
- 0.3%
- Act
- Fcst
- 1.451 M
- Prev
- 3.391 M
- Act
- Fcst
- -0.090 M
- Prev
- 0.745 M
- Act
- Fcst
- Prev
- 1.843%